RIQAS Blood Typing EQA Programme – Cycle Starts January 2025
The RIQAS Blood Typing Programme will run at a frequency of two challenges, quarterly across a 12-month period. The samples will be supplied in a liquid ready-to-use format. Suitable for both manual and automated systems.
Monitoring of blood typing assessments to ensure an accurate determination of ones blood type is essential to minimise the possibility of complications during blood transfusion, organ transplantation or pregnancy.
- Comprehensive yet easy to interpret report
- Suitable for use on both manual and automated methods
- Report turnaround time of less than 72-hours
- Liquid ready-to-use samples
- Suitable for use in Clinical Laboratories, Blood Banks and Blood Transfusion Centres
- Regular performance review from two patient samples
- Cycle Starts – January 2025
Not accredited to ISO 17043
Please note, product availability may vary country to country.
Cat No | Kit Size | Frequency | Parameters | |
---|---|---|---|---|
RQ9206 | 2 x Patient 15% (±2%) Simulated Whole Blood 4 mL - 1x Donor 25% (±2%) RBC Suspension 2 mL | Quarterly | 6 parameters | |
By providing carefully selected samples with known RBC antigens and serum antibodies, the RIQAS Blood Typing Programme is designed to monitor a lab’s ability to correctly determine the outcome of the following tests:
- ABO Group
- Antibody Identification
- Antibody Screen
- Antigen Typing
- Compatability (Cross-match)
- Rh(D)